Previous 10 | Next 10 |
home / stock / rhhvf / rhhvf news
2023-07-11 19:31:22 ET Summary Aclaris Therapeutics, Inc. results from a phase 2b study using zunsemetinib for the treatment of patients with rheumatoid arthritis are expected to be released by Q4 of 2023. The global rheumatoid arthritis market is expected to reach $33.3 billion b...
2023-07-07 14:00:03 ET Summary Shares of diagnostics and drug discovery concern Adaptive Biotechnologies Corporation have crashed over 90% as the commercial-stage concern struggles with profitability. On the top line, the company’s clonoSEQ test volume increased 57% year-ov...
2023-07-05 19:52:43 ET Summary Investors today are starved for income due to the rapidly rising cost of living. ETW invests in a portfolio of common stocks and then writes options against various indices in an attempt to earn income via the option premium. The fund is technica...
2023-07-03 17:39:47 ET Summary Positive results achieved, in using pelareorep + paclitaxel for the treatment of HR+/HER2- metastatic breast cancer patients, in the phase 2 BRACELET-1 study. Preparation is underway to initiate a phase 3 study using pelareorep + paclitaxel for the t...
2023-06-23 17:57:53 ET Summary Europe is a relevant place for investment due to its role as one of the world's leading economic areas. Europe is home to many well-established multinational companies. Major European stock indices have a lower average valuation and a higher dividend...
2023-06-17 16:00:00 ET Biologic drugs, among the most expensive medications that are often used in treating cancer and rare diseases, will propel European pharmaceutical companies to achieve more in sales than their US counterparts. By 2028, three of the top five pharma companies in ter...
2023-06-13 17:55:37 ET Summary Regeneron Pharmaceuticals, Inc. has potential to receive FDA approval of higher dosing of 8 mg of EYLEA, which has been set with an FDA target action date of June 27, 2023. The additional indication in preterm infants with retinopathy of prematurity ...
2023-06-11 12:00:02 ET Driven by novel therapeutics from Biogen ( NASDAQ: BIIB )/ Eisai ( OTCPK:ESALF ) and Eli Lilly ( NYSE: LLY ), the Alzheimer’s disease market across eight major countries will reach $13.7B in 2030, the data analytics firm, GlobalData said las...
2023-06-09 12:32:12 ET Summary Today, we take our first look at a commercial stage biopharma concern called Kiniksa Pharmaceuticals, Ltd. The company is seeing impressive growth from its primary drug asset and has an intriguing pipeline. An investment analysis follows in the p...
2023-05-30 11:02:01 ET Rain Oncology ( NASDAQ: RAIN ) shed ~9% in the morning hours Tuesday after announcing layoffs, the departure of the company’s chief medical officer, and changes to its clinical programs for lead candidate milademetan. As part of efforts to strea...
News, Short Squeeze, Breakout and More Instantly...
Roche Holding Div Rts Company Name:
RHHVF Stock Symbol:
OTCMKTS Market:
Roche Holding Div Rts Website:
Roche introduces navify® Algorithm Suite, a digital library of medical algorithms that enhances clinical decision-making to optimise patient care Canada NewsWire At the global HIMSS 1 Conference, Roche showcases navify Algorithm Suite, a single platform offering cli...
Roche Announces Brad Moore as President and CEO of Roche Diagnostics North America PR Newswire INDIANAPOLIS , Dec. 5, 2022 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of Brad Moore as president and CEO of Roche Diagnost...